Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials

被引：0
|
作者：
F. Ziemssen
N. Feltgen
FG. Holz
R. Guthoff
A. Ringwald
T. Bertelmann
A. Wiedon
C. Korb
机构：
[1] Eberhard-Karls-University Tuebingen,Centre for Ophthalmology
[2] University Eye Hospital Goettingen,Department of Ophthalmology
[3] University of Bonn,University Eye Hospital
[4] Heinrich-Heine-University Duesseldorf,Klinikum Dortmund
[5] University of Muenster,Department of Ophthalmology, and Novartis Pharma GmbH
[6] Georg-August-University Goettingen,Department of Ophthalmology
[7] Novartis Pharma GmbH,undefined
[8] University Medical Center Mainz,undefined
来源：
BMC Ophthalmology | / 17卷
关键词：
NAMD; DME; RVO; Non-interventional study; Demographic characteristics; Anti-VEGF; Epidemiology; Ceiling effect;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials
    Ziemssen, F.
    Feltgen, N.
    Holz, F. G.
    Guthoff, R.
    Ringwald, A.
    Bertelmann, T.
    Wiedon, A.
    Korb, C.
    BMC OPHTHALMOLOGY, 2017, 17
  • [2] Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research
    Scondotto, Giulia
    Crisafulli, Salvatore
    Antonazzo, Ippazio Cosimo
    Virgili, Gianni
    Trifiro, Gianluca
    Sultana, Janet
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (02) : 205 - 214
  • [3] A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment
    Hsieh, Tsung-Cheng
    Deng, Guang-Hong
    Chang, Yung-Ching
    Chang, Fang-Ling
    He, Ming-Shan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] Treatment of Retinal Angiomatous Proliferation with Intravitreal Anti-VEGF Drugs in Real Life Practice
    Parodi, Maurizio Battaglia
    Donati, Simone
    Azzolini, Claudio
    Pece, Alfredo
    Bottoni, Ferdinando
    Danzi, Paola
    Introini, Ugo
    Pucci, Vincenzo
    Semeraro, Francesco
    Viola, Francesco
    Luce, Progetto
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [5] Treatment of Retinal Angiomatous Proliferation with Intravitreal Anti-VEGF Drugs in Real Life Practice
    Parodi, Maurizio Battaglia
    Danzi, Paola
    Semeraro, Francesco
    Donati, Simone
    Azzolini, Claudio
    Pece, Alfredo
    Pucci, Vincenzo
    Musig, Andrea
    OPHTHALMOLOGICA, 2014, 232 : 10 - 11
  • [6] Anti-VEGF for diabetic retinopathy treatment: systematic review of randomized controlled trials
    Le, Laura
    Latkany, Paul
    Kothari, Nikisha
    Scott, Nathan
    Rodriguez, Marianeli
    Patel, Nimesh
    Yannuzzi, Nicolas
    Haskova, Zdenka
    Callaway, Natalia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [7] Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting
    Jan Niklas Lüke
    Hamdi Alquoqa
    Ahmad Alsamman
    Bayan Aljabary
    F. Schaub
    L. M. Heindl
    International Ophthalmology, 2023, 43 : 13 - 25
  • [8] Anti-VEGF Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2018, 196 : 208 - 209
  • [9] Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal
    Vaz-Pereira, Sara
    Marques, Ines P.
    Matias, Joao
    Mira, Filipe
    Ribeiro, Ligia
    Flores, Rita
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2017, 27 (06) : 756 - 761
  • [10] Three-year real-world outcomes of intravitreal anti-VEGF therapies in patients affected by myopic choroidal neovascularization
    Corazza, Paolo
    Kabbani, Jamil
    Soomro, Taha
    Alam, Mostafa Mohamed Ragheb
    D'Alterio, Francesco Maria
    Younis, Saad
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (05) : 2481 - 2487
12345